Your browser doesn't support javascript.
loading
Understanding the Impact of Pneumonia and Other Complications in Elderly Liver Transplant Recipients: An Analysis of NSQIP Transplant.
Schnickel, Gabriel T; Greenstein, Stuart; Berumen, Jennifer A; Elias, Nahel; Sudan, Debra L; Conzen, Kendra D; Mekeel, Kristin L; Foley, David P; Hirose, Ryutaro; Parekh, Justin R.
Afiliación
  • Schnickel GT; Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego, San Diego, CA.
  • Greenstein S; Montefiore Einstein Center for Transplantation, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
  • Berumen JA; Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego, San Diego, CA.
  • Elias N; Harvard Medical School, Boston, MA.
  • Sudan DL; Massachusetts General Hospital Transplant Center, Massachusetts General Hospital, Boston, MA.
  • Conzen KD; Transplant Surgery Division, Massachusetts General Hospital, Boston, MA.
  • Mekeel KL; Division of Abdominal Transplant Surgery, Department of Surgery, Duke University Medical Center, Durham, NC.
  • Foley DP; Division of Transplant Surgery, University of Colorado School of Medicine, Aurora, CO.
  • Hirose R; Division of Transplant and Hepatobiliary Surgery, Department of Surgery, University of California San Diego, San Diego, CA.
  • Parekh JR; University of Wisconsin, School of Medicine and Public Health, Madison, WI.
Transplant Direct ; 7(5): e692, 2021 May.
Article en En | MEDLINE | ID: mdl-33912659
Despite an increasing demand for liver transplantation in older patients, our understanding of posttransplant outcomes in older recipients is limited to basic recipient and graft survival. Using National Surgical Quality Improvement Program Transplant, we tracked early outcomes after liver transplantation for patients >65. METHODS: We conducted a retrospective analysis of patients in National Surgical Quality Improvement Program Transplant between March 1, 2017 and March 31, 2019. Recipients were followed for 1 y after transplant with follow-up at 30, 90, and 365 d. Data were prospectively gathered using standard definitions across all sites. RESULTS: One thousand seven hundred thirty-one adult liver transplants were enrolled; 387 (22.4%) were >65 y old. The majority of older recipients were transplanted for hepatocellular carcinoma. The older cohort had a lower lab Model for End-Stage Liver Disease and was less likely to be hospitalized at time of transplant. Overall, older recipients had higher rates of pneumonia but no difference in intensive care unit length of stay (LOS), total LOS, surgical site infection, or 30-d readmission. Subgroup analysis of patients with poor functional status revealed a significant difference in intensive care unit and total LOS. Pneumonia was even more common in older patients and had a significant impact on overall survival. CONCLUSIONS: By targeting patients with hepatocellular carcinoma and lower Model for End-Stage Liver Diseases, transplant centers can achieve nearly equivalent outcomes in older recipients. However, older recipients with poor functional status require greater resources and are more likely to develop pneumonia. Pneumonia was strongly associated with posttransplant survival and represents an opportunity for improvement. By truly understanding the outcomes of elderly and frail recipients, transplant centers can improve outcomes for these higher-risk recipients.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Transplant Direct Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Transplant Direct Año: 2021 Tipo del documento: Article